Bandingkan Harga & Kinerja Rans Entertainmen Indonesia Tbk (RANS) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Rans Entertainmen Indonesia Tbk dan Organon Pharma Indonesia Tbk.: Rans Entertainmen Indonesia Tbk diperdagangkan di Rp200 (kapitalisasi pasar 2,57 T, volume 24 jam 67,92 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Rans Entertainmen Indonesia Tbk jauh lebih besar — sekitar 24,6× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| RANS | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 2,57 T | 104,4 M |
Volume | 67,92 jt | — |
Lot | 679,19 rb | — |
Perputaran | 13,51 M | — |
Harga Rata-rata | 198,89 | — |
Nilai Transaksi | 13,51 M | — |
Harga Ekuilibrium Indikatif | 200 | — |
Volume Ekuilibrium Indikatif | 4,66 rb | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Rans Entertainmen Indonesia Tbk
PT. Rans Entertainmen Indonesia Tbk. (the Company) was established with Deed No. 04 on October 18, 2016, which was made before Raden Mas Dendy Subangil S.H., M.Kn., under the name of PT RNR Film Internasional. The Company started its commercial operations in 2018. The Company does not have a parent entity, the ultimate controlling party is Raffi Farid Ahmad as the Companys shareholder.
Selengkapnya di halaman RANS →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
